PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

End-of-life systemic treatment for patients with advanced cancers does not improve survival

Study reinforces importance of providers focusing on supportive end-of-life care aligned with patient preferences

2024-05-16
(Press-News.org) Patients with very advanced solid tumors saw no significant improvement in overall survival after receiving systemic therapy, according to a study published today in JAMA Oncology by researchers at The University of Texas MD Anderson Cancer Center and Yale Cancer Center.

The findings provide further evidence to help oncologists counsel patients that additional cancer-directed therapy is not likely to benefit them, allowing them to focus instead on palliative and supportive care options that have been demonstrated to improve quality of life and survival.

“Our study highlights the importance of open and honest communication about prognosis between providers and patients,” said senior author Kerin Adelson, M.D., chief quality and value officer at MD Anderson. “Our findings may help oncologists reconsider treatment and instead provide patients with transparent information on supportive care options so they are able to make informed decisions.”

Adelson and colleagues analyzed de-identified data from more than 78,000 adult patients treated at 144 community oncology practices and academic/research centers. Patients included in the study were diagnosed between 2015 and 2019 with metastatic or advanced disease in one of the six common cancers: breast, colorectal, non-small cell lung, pancreatic, renal cell carcinoma, and urothelial cancers.

Researchers stratified oncology practices by how frequently providers gave systemic therapy for very advanced cancers and then studied overall survival of patients with six common solid tumor types treated in these practices. They found no difference in patient survival among practices that gave more systemic therapy for very advanced cancer compared with those who gave less.

“A large body of research has shown that goals-of-care conversations are critical to ensuring patients receive care in line with their prognosis and personal goals. This is even more critical when we know additional therapy will not improve a patient’s survival, but only cause toxicity and harm,” Adelson said.

As part of its institutional Strategy, MD Anderson is working to ensure goal-concordant care for its patients. This multidisciplinary approach integrates a patient’s individual values and goals into their care plans. MD Anderson is developing a number of strategies to encourage and streamline early conversations about goals of care, and the institution is identifying ways to restructure and realign resources related to palliative and end-of-life care.

Adelson began this research while at Yale Cancer Center. This study was supported by Flatiron Health. A full list of co-authors and disclosures is available here.

END


ELSE PRESS RELEASES FROM THIS DATE:

To optimize guide-dog robots, first listen to the visually impaired

To optimize guide-dog robots, first listen to the visually impaired
2024-05-16
May 16, 2024    To Optimize Guide-Dog Robots, First Listen to the Visually Impaired     Award-winning research led by UMass Amherst shows to be successful, Guide-dog users and trainers need to provide insight into features that make robotic helpers useful in the real world    AMHERST, Mass. — What features does a robotic guide dog need? Ask the blind, say the authors of an award-winning paper. Led by researchers at the University of Massachusetts Amherst, a study identifying how to develop robot guide dogs with insights from guide dog users and trainers won a Best Paper Award at ...

Imaging fibrous structure abnormalities of the white of the eye in myopathic patients

Imaging fibrous structure abnormalities of the white of the eye in myopathic patients
2024-05-16
Researchers provide an innovative approach to understanding ocular pathologies by visualizing the fiber structure of the sclera, the outermost eye layer   Tokyo, Japan – Eye diseases are extremely prevalent worldwide, with recent estimates suggesting that one-third of the global population suffers from some type of vision impairment. Given the high complexity of the human eye, the precise origin and nature of many eye diseases remain unclear, leaving affected people with limited diagnostic and treatment options.   Now, in a study made available online on March 7, 2024 and published in Volume 142, Number 4 of JAMA Ophthalmology on ...

Loneliness and mental health problems are interconnected

Loneliness and mental health problems are interconnected
2024-05-16
“We have found a correlation between loneliness and several mental health problems,” says Associate Professor Rubén Rodríguez-Cano at the Norwegian University of Science and Technology (NTNU’s) Department of Psychology. In a new study, researchers are looking at whether lonely people are more prone to problems such as depression and psychosis. Based on medication use, the correlation is clear. “The risk of a lonely person also struggling with mental health problems is greater than for people who ...

Dr. Daniel Geynisman named new Editor-in-Chief for JNCCN—Journal of the National Comprehensive Cancer Network

Dr. Daniel Geynisman named new Editor-in-Chief for JNCCN—Journal of the National Comprehensive Cancer Network
2024-05-16
PLYMOUTH MEETING, PA [May 16, 2024] — Daniel M. Geynisman, MD, is being announced as the new Editor-in-Chief for JNCCN—Journal of the National Comprehensive Cancer Network. Dr. Geynisman has a long history of working with NCCN in a variety of roles and served as medical oncology section editor for Urologic Oncology: Seminars and Original Investigations since 2018 and authored more than 130 peer-reviewed publications. He is an Associate Professor in the Department of Hematology/Medical Oncology and Chief of the Division of Genitourinary Medical Oncology at Fox Chase Cancer Center. “We are thrilled to welcome Dr. Geynisman into this ...

A new and better way to detect media censorship

A new and better way to detect media censorship
2024-05-16
Worldwide news media are facing increasing pressure from autocrats to report favourably about their leaders and party politics. Political scientists launch a new computational method that can detect such media censorship by states while it is happening. This method provides valuable insights for  communicating regime-driven media capture to the public. It is now described in detail in the scientific journal ‘Democratization’. One of the first steps of would-be autocrats is to control the ...

Listening to muscles

2024-05-16
Spinal muscular atrophy or “SMA” for short is a terrible disease in which a genetic mutation causes certain nerves responsible for sending signals to muscles to degenerate. This leads to muscles wasting away, and many patients have died a painful death due to this rare condition. Genetic treatments have only been available for a few years. Now, a team led by Emmanuel Nedoschill, Ferdinand Knieling and Adrian Regensburger from the “Translational Pediatrics” working group at the Department of Pediatrics and Adolescent Medicine at Uniklinikum Erlangen have devised ...

Spider silk sound system #ASA186

Spider silk sound system #ASA186
2024-05-16
OTTAWA, Ontario, May 16, 2024 – The best microphone in the world might have an unexpected source: spider silk. Spiders weave webs to trap their insect snacks, but the sticky strands also help spiders hear. Unlike human eardrums and conventional microphones that detect sound pressure waves, spider silk responds to changes in the velocities of air particles as they are thrust about by a sound field. This sound velocity detection method remains largely underexplored compared to pressure sensing, but it holds great potential for high-sensitivity, long-distance sound detection. Researchers ...

Equitable opportunity for transplants: Experts provide disparity-sensitive measures for transplant centers

2024-05-16
INDIANAPOLIS – An Expert Insight, published in the journal Transplantation, highlights health equity, disparity and inequality in organ transplantation along the continuum of care and across organ types. The authors provide a guide to transplant centers for the use of disparity-sensitive measures to monitor and address health disparities in transplantation and to redress long-standing inequities and inequalities in this vital arena. “Our goal is to ensure that all patients who need a transplant have ...

Gene therapy relieves back pain, repairs damaged disc in mice

2024-05-16
COLUMBUS, Ohio – Disc-related back pain may one day meet its therapeutic match: gene therapy delivered by naturally derived nanocarriers that, a new study shows, repairs damaged discs in the spine and lowers pain symptoms in mice. Scientists engineered nanocarriers using mouse connective-tissue cells called fibroblasts as a model of skin cells and loaded them with genetic material for a protein key to tissue development. The team injected a solution containing the carriers into damaged discs in mice at the same time the back injury ...

To sound like a hockey player, speak like a Canadian #ASA186

To sound like a hockey player, speak like a Canadian #ASA186
2024-05-16
OTTAWA, Ontario, May 16, 2024 – As a hockey player, Andrew Bray was familiar with the slang thrown around the “barn” (hockey arena). As a linguist, he wanted to understand how sport-specific jargon evolved and permeated across teams, regions, and countries. In pursuit of the sociolinguistic “biscuit” (puck), he faced an unexpected question. “It was while conducting this initial study that I was asked a question that has since shaped the direction of my subsequent research,” said Bray. “‘Are you trying to figure out why the Americans sound like fake Canadians?’”  Canadian ...

LAST 30 PRESS RELEASES:

Phase III trial finds hypofractionated radiotherapy with chemotherapy offers comparable survival and lower toxicity to conventional schedule in LS-SCLC

Lung cancer screening benefits adults up to age 80 if surgical candidates, UK study finds

Video assisted thoracoscopy surgery reduces mortality by 21 percent compared to lobectomy

NADIM ADJUVANT trial suggests benefit of adjuvant chemo-immunotherapy in resected stage IB–IIIA NSCLC

EA5181 phase 3 trial finds no OS benefit for concurrent and consolidative durvalumab vs consolidation alone in unresectable stage 3 NSCLC

Training to improve memory

Are patients undergoing surgery for early-stage cancer at risk of persistent opioid use?

Black youth, especially Black girls, use mental health services less than their White peers

Canada must protect youth from sports betting advertising

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

AI helped older adults report accurate blood pressure readings at home

High blood pressure in childhood and premature cardiovascular disease mortality

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC

CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC

Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital

New medication lowered hard-to-control high blood pressure in people with chronic kidney disease

Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment

New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment

Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor

Study prompts new theory of human-machine communication

New method calculates rate of gene expression to understand cell fate

[Press-News.org] End-of-life systemic treatment for patients with advanced cancers does not improve survival
Study reinforces importance of providers focusing on supportive end-of-life care aligned with patient preferences